Health committee  Yes, it's a solution. As I have been saying since earlier, the list price, the catalogue price, is one issue. I see agreement that people are paying too much for drugs in Canada. I'm a taxpayer like everyone else and I have nothing against motherhood and apple pie. However, in m

Health committee  The life science sector is important. If we haven't actually drawn that learning from the pandemic, I don't know what is important to take from it. I don't represent a multinational. I'm a homegrown pharmaceutical company. We don't have a lot of those. As Dr. Grover was just say

Health committee  Okay.

Health committee  No, go ahead. I'll complement you.

Health committee  If a Canadian drug is half the price of its U.S. equivalent, we will not be able to launch it. I can tell you that right now. I have to deal with situations like that. No one else in the company makes those kinds of decisions but me. If a drug sells for $100,000 in the United St

Health committee  Thank you, Ms. Perrault. Good afternoon, everyone. I am pleased to join you today through technology. As a former CEO of a Canadian biopharma firm, it is my role today to tell you that if this reform goes forward, it will contribute to delaying and reducing the amount of in